{"id":382564,"date":"2020-11-17T05:03:14","date_gmt":"2020-11-17T10:03:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382564"},"modified":"2020-11-17T05:03:14","modified_gmt":"2020-11-17T10:03:14","slug":"caredx-receives-medicare-reimbursement-pricing-for-allosure-heart","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/","title":{"rendered":"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Nov.  17, 2020  (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has received final reimbursement pricing of $2,753 from Palmetto MolDx for AlloSure Heart.<\/p>\n<p>AlloSure Heart is a donor-derived cell-free DNA (dd-cfDNA) test which can identify underlying cell injury leading to organ rejection, and is covered by Medicare when used in conjunction with AlloMap Heart gene expression profiling. HeartCare, the combination of AlloSure Heart and AlloMap Heart, provides a multi-modality and non-invasive solution for managing the care of transplant patients.<\/p>\n<p>\u201cWe are pleased to reach this milestone for AlloSure Heart which broadens accessibility to HeartCare, and improves management of heart transplant patients,\u201d said Reg Seeto, President and Chief Executive Officer. \u201cThis non-invasive, multi-modality solution represents the latest innovation in precision medicine. HeartCare will help redefine the way clinicians manage the care of transplant patients.\u201d<\/p>\n<p>\n        <strong>About<\/strong><br \/>\n        <strong>\u00a0<\/strong><br \/>\n        <strong>CareDx<\/strong><br \/>\n        <br \/>CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients. For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PMH796rJiorO7BOeqB5DQE3acy4kFaJmqSxf8PJgQk5GuAoOFEcVLdIcDtnpuf3c9IypgDSNDaPHh7cipKU6ig==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.CareDx.com<\/a>.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p>CareDx, Inc.<br \/>Sasha King<br \/>Chief Marketing Officer<br \/>415-287-2393<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gcXaK-nctC3T3OTfvmkVAwOQ91gaehohsxaJFdTIMTavjvuEDuV4RbjptUw6TNgud3FDOq1j5FcEW6PJtUywbg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">sking@caredx.com<\/a><\/p>\n<p>Investor Relations<br \/>Greg Chodaczek<br \/>347-620-7010<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g5x8B07cz2Tx3KosoZNrXZ_8pLFe51UqPzC4qJg8gbCEo_NvHOk-PyefG0IXxlLJ7RUvmAcdLpUSaUTCPdi3VXpELIlVu6gEec8YlOlsDjw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investor@caredx.com<\/a><\/u>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ac89a3f6-861f-42c0-8791-d78bf679d8e2\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has received final reimbursement pricing of $2,753 from Palmetto MolDx for AlloSure Heart. AlloSure Heart is a donor-derived cell-free DNA (dd-cfDNA) test which can identify underlying cell injury leading to organ rejection, and is covered by Medicare when used in conjunction with AlloMap Heart gene expression profiling. HeartCare, the combination of AlloSure Heart and AlloMap Heart, provides a multi-modality and non-invasive solution for managing the care of transplant patients. \u201cWe are pleased to reach this milestone for AlloSure Heart which broadens accessibility &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382564","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has received final reimbursement pricing of $2,753 from Palmetto MolDx for AlloSure Heart. AlloSure Heart is a donor-derived cell-free DNA (dd-cfDNA) test which can identify underlying cell injury leading to organ rejection, and is covered by Medicare when used in conjunction with AlloMap Heart gene expression profiling. HeartCare, the combination of AlloSure Heart and AlloMap Heart, provides a multi-modality and non-invasive solution for managing the care of transplant patients. \u201cWe are pleased to reach this milestone for AlloSure Heart which broadens accessibility &hellip; Continue reading &quot;CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T10:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart\",\"datePublished\":\"2020-11-17T10:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/\"},\"wordCount\":257,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/\",\"name\":\"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=\",\"datePublished\":\"2020-11-17T10:03:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/","og_locale":"en_US","og_type":"article","og_title":"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; CareDx, Inc.\u00a0(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it has received final reimbursement pricing of $2,753 from Palmetto MolDx for AlloSure Heart. AlloSure Heart is a donor-derived cell-free DNA (dd-cfDNA) test which can identify underlying cell injury leading to organ rejection, and is covered by Medicare when used in conjunction with AlloMap Heart gene expression profiling. HeartCare, the combination of AlloSure Heart and AlloMap Heart, provides a multi-modality and non-invasive solution for managing the care of transplant patients. \u201cWe are pleased to reach this milestone for AlloSure Heart which broadens accessibility &hellip; Continue reading \"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T10:03:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart","datePublished":"2020-11-17T10:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/"},"wordCount":257,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/","name":"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=","datePublished":"2020-11-17T10:03:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzMxNSMzODMwNzMyIzIwMDQ1MDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caredx-receives-medicare-reimbursement-pricing-for-allosure-heart\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382564"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382564\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}